Drug-resistant infections team

We work with experts and partner organisations, including research, policy and industry experts, clinical scientists, product developers, NGOs and funders, to explore global solutions to drug-resistant infections.

Contact us

To contact the team, email drugresistantinfections@wellcome.ac.uk.

Team contacts

Tim Jinks

Head of Drug-resistant Infections Programme

Jeremy Knox

Policy and Advocacy Lead

Rebecca Sugden

Policy Adviser

Sian Williams

Policy Officer

Oliver Williams

Policy Officer

Gemma Buckland-Merrett

Science Innovation Lead

Francesca Chiara

Science Officer

Janet Midega

Science Officer

Joanna Wiecek

Science Officer

Chibuzor Uchea

Science Officer

Charlotte Chapman

Programme Manager

Janvi Patel

PA/Team Coordinator

Veronika Jacobi

Team Administrator

Our work

Drug-resistant infections: transforming the global response

The collective overuse of antibiotics has caused one of the most urgent health problems. We want to transform the world's response towards stemming the rise of drug-resistant infections.

Reports

Report 29 October 2019 Updated 4 December 2019

Reframing Resistance

DownloadPDF 1.1MB

This report aims to guide experts, communicators and practitioners to communicate with impact, so that the public understands and supports action on drug-resistant infections.

Report 14 October 2019 Updated 10 March 2020

Reframing Resistance

[Summary] This report aims to help experts and practitioners to communicate with impact, so that the public understands and supports action on drug-resistant infections.

Briefings and responses

Consultation response Updated 26 March 2020

Response to the Indian Government on the open consultation for proposed Environment (Protection) Amendment Rules 2020

DownloadPDF 141KB

The Indian Ministry of Environment, Forest and Climate Change issued the draft notification Environment Protection Amendment Rules 2020, setting out proposed national standards for levels of antimicrobials released in pharmaceutical manufacturing effluent. As a potential driver of antimicrobial resi